Coronavirus Usa Los Angeles hospital Government patient Coronavirus Usa Los Angeles

Coronavirus treatment Remdesivir to cost $3,120 for US patients with private insurance

LOS ANGELES - On Monday, Gilead Sciences Inc. announced its pricing plans for the coronavirus drug Remdesivir, stating it will charge hospitals $3,120 for a patient in the United States with private insurance.“There is no playbook for how to price a new medicine in a pandemic,” Daniel O’ Day, chairman & CEO of Gilead Sciences said in an open letter. “We approached this with the aim of helping as many patients as possible, as quickly as possible and in the most responsible way.”The drugmaker announced the price would be set to $390 per vial for governments of developed countries.

All news from

The website is not a news writer, but just an aggregator. The site publishes announcements of the materials taken from the open sources. The news source is indicated at the beginning and at the end of the announcement. As a part of the fight against fakes, you can send a complaint on the news, and we will consider your complaint as soon as possible.

Related News

Breaking news
Lawmakers vote closes down Philippines' largest TV network
Guelph, Ont. long-term care worker tests positive for coronavirus
(VIDEO) Ex-OIC of the PNB obstructs the duties of a photo-journalist